Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancer
(MedPage Today) -- Gene-guided treatment selection for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) failed to improve disease control versus random treatment selection in a small preliminary clinical trial. Personalized treatment... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 4, 2024 Category: Hematology Source Type: news

Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results
(MedPage Today) -- Two first-line trials involving pembrolizumab (Keytruda)-based combinations for the treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) delivered mixed results. While first-line pembrolizumab plus... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 1, 2024 Category: Hematology Source Type: news

Head and neck oncology professionals' perceptions of suicide risk screening among patients - Adjei Boakye E, Sykes KJ, Hamilton JL, Cash ED, Duffy NM, Maurer S, Williams AM.
Suicide risk occurs along the cancer care continuum, from new diagnosis through survivorship.[1] Patients with head and neck cancer (HNC) are twice as likely to die from suicide compared with patients with other cancers.[2] Despite this elevated suicide ri... (Source: SafetyLit)
Source: SafetyLit - February 27, 2024 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news

' Eating As Treatment' Linked to Improved Survival in HNC'Eating As Treatment' Linked to Improved Survival in HNC
An oncology dietician-led intervention improved nutritional status and significantly reduced 5-year mortality in patients with head and neck cancer undergoing radiotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 26, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Miami Cancer Institute to host second Precision Oncology Symposium to advance cancer treatment
Miami Cancer Institute, part of Baptist Health South Florida, will host its second annual Precision Oncology Symposium from April 19-20, according to the symposium organizers. This one-and-a-half-day symposium, to be held in Miami, has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of solid tumors — including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas, and brain… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 19, 2024 Category: Biotechnology Authors: Baptist Health Source Type: news

'If Philips had done something, my husband would still be here' - Widow claims spouse, 51, died from rare throat cancer linked to sleep apnea machine he bought to stop snoring
Rodney Thomas (pictured) from Louisiana was 51 years old when he died from nasopharyngeal cancer, a rare type of head and neck cancer, after using a Philips sleep apnea machine. (Source: the Mail online | Health)
Source: the Mail online | Health - February 17, 2024 Category: Consumer Health News Source Type: news

IAEA touts radiotherapy trial in low-income countries
The International Atomic Energy Agency (IAEA) highlighted a study it led suggesting that fewer but higher doses of radiation treatment for head and neck cancer resulted in similar results as standard radiotherapy in patients in low-income countries. “Reducing overall treatment times for this type of cancer could help countries to shorten waitlists, enabling more patients to receive timely treatment while also reducing the cost and full treatment duration,” the IAEA said in a recent news release. The trial involved 12 centers in ten low- and middle-income countries (LMICs) – Argentina, Brazil, Cuba, India, Indonesia...
Source: AuntMinnie.com Headlines - February 7, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Why choose Mayo Clinic for head and neck cancers
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - February 2, 2024 Category: Consumer Health News Source Type: news

FAPI-PET shows promise in head and neck cancer patients
In this study, the researchers tested the approach for the first time in head and neck cancer patients with tumors of unknown origin in a prospective clinical trial.PET/CT and MR images of a 72-year-old woman. (A) F-18 FDG-PET images (left and top) and PET/CT images (bottom) shown in coronal, sagittal, and axial views (from left to right), demonstrated a metastatic lymph node of the right neck with intensive metabolic activity (black arrow, SUVmax, 30.1) but presented no evidence for primary tumor. (B) Ga-68 FAPI-PET images (top and right) and PET/CT images (bottom), shown in axial, sagittal, and coronal views (from left t...
Source: AuntMinnie.com Headlines - January 26, 2024 Category: Radiology Authors: Will Morton Tags: Molecular Imaging Radiation Oncology/Therapy Source Type: news

People urged to get HPV vaccine by health chiefs as figures show low vaccination rates
The HPV vaccine helps protect against a range of cancers, including cervical, head and neck, anal and genital cancers, which can affect both girls and boys. (Source: Daily Express - Health)
Source: Daily Express - Health - January 23, 2024 Category: Consumer Health News Source Type: news

Decrease in Head and Neck Cancer Incidence Seen During Pandemic
FRIDAY, Jan. 12, 2024 -- During the first year of the COVID-19 pandemic, the incidence of head and neck cancer (HNC) decreased, according to a study published online Jan. 11 in JAMA Otolaryngology-Head& Neck Surgery.Jason Semprini, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 13, 2024 Category: Pharmaceuticals Source Type: news

Point-of-care decision support reduces unnecessary CT, MRI imaging
A point-of-care, web-based clinical decision support tool shows promise for not only reducing the incidence of inappropriate CT or MR imaging but also patients' radiation exposure and even carbon emissions caused by unnecessary exams, researchers have found. "[Our study found that] implementation of the point-of-care clinical decision support tool reduced the number of patients who simultaneously had a CT and MRI ordered for the same clinical indication compared to a standalone web-based clinical decision support tool," wrote a group led by medical student Amy Schranz of University College Dublin in Ireland. The team's fi...
Source: AuntMinnie.com Headlines - January 11, 2024 Category: Radiology Authors: Kate Madden Yee Tags: Practice Management MRI Source Type: news

Head and Neck Cancer Market Size & Share to Surpass USD 2.9 billion by 2031
Wilmington, Delaware, United States, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Head and neck cancer market was valued at US$ 1.6 billion in 2022. A CAGR of 6.8% is predicted from 2023 to 2031. Head and neck cancer market is expected to reach US$ 2.9 billion by the end…#wilmington #delaware #healthcare #samplepdf #latinamerica #middleeast #africa #hpv #access (Source: Reuters: Health)
Source: Reuters: Health - January 2, 2024 Category: Consumer Health News Source Type: news

Consumption of Ultra-Processed Foods Tied to Upper Digestive Tract Cancers
FRIDAY, Dec. 22, 2023 -- Higher ultra-processed food (UPF) consumption is associated with a greater risk for head and neck cancer (HNC) and esophageal adenocarcinoma (OAC), according to a study published online Nov. 22 in the European Journal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 22, 2023 Category: Pharmaceuticals Source Type: news